(AKZA) Akzo Nobel - Ratings and Ratios
Exchange: AS •
Country: Netherlands •
Currency: EUR •
Type: Common Stock •
ISIN: NL0013267909
Decorative Paints, Performance Coatings
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.51% |
| Yield on Cost 5y | 2.65% |
| Yield CAGR 5y | 0.25% |
| Payout Consistency | 90.8% |
| Payout Ratio | 132.0% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.5% |
| Value at Risk 5%th | 31.9% |
| Relative Tail Risk | -5.51% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.05 |
| Alpha | -5.58 |
| CAGR/Max DD | -0.07 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.506 |
| Beta | 0.226 |
| Beta Downside | 0.143 |
| Drawdowns 3y | |
|---|---|
| Max DD | 34.78% |
| Mean DD | 16.38% |
| Median DD | 18.31% |
Description: AKZA Akzo Nobel January 02, 2026
Akzo Nobel N.V. (ticker AKZA) is a global paints and coatings producer organized into two core segments: Decorative Paints, which supplies paints, lacquers, varnishes and color-mixing equipment for building, renovation and automotive markets; and Performance Coatings, which provides protective and functional finishes for ships, cars, aircraft, yachts, architectural components, consumer goods, oil-&-gas facilities and powder-coat applications.
In FY 2023 the company generated approximately €12.5 billion of revenue, with an EBIT margin of roughly 13 %, reflecting the relatively high-value nature of its specialty-chemical portfolio. Key economic drivers include construction-sector cyclicality (which directly impacts Decorative Paints demand), raw-material cost volatility (especially solvents and titanium dioxide), and the ongoing shift toward high-performance, low-VOC powder coatings that benefit from stricter environmental regulations. The firm’s exposure to capital-intensive end-markets such as shipbuilding and automotive aligns its performance with global industrial activity trends.
For a deeper, data-driven assessment of AKZA’s valuation and risk profile, you may find ValueRay’s analytical dashboard useful.
Piotroski VR‑10 (Strict, 0-10) 2.5
| Net Income (415.0m TTM) > 0 and > 6% of Revenue (6% = 631.6m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -1.27pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 11.10% (prev 5.16%; Δ 5.93pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 814.0m > Net Income 415.0m (YES >=105%, WARN >=100%) |
| Net Debt (3.77b) to EBITDA (1.17b) ratio: 3.23 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.23 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (171.0m) change vs 12m ago 0.12% (target <= -2.0% for YES) |
| Gross Margin 39.85% (prev 40.90%; Δ -1.05pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 73.47% (prev 73.83%; Δ -0.36pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 4.42 (EBITDA TTM 1.17b / Interest Expense TTM 179.0m) >= 6 (WARN >= 3) |
ValueRay F-Score (Strict, 0-100) 55.89
| 1. Piotroski 2.50pt |
| 2. FCF Yield 3.52% |
| 3. FCF Margin 4.56% |
| 4. Debt/Equity 1.22 |
| 5. Debt/Ebitda 3.23 |
| 6. ROIC - WACC (= 3.33)% |
| 7. RoE 9.25% |
| 8. Rev. Trend 26.11% |
| 9. EPS Trend -22.95% |
What is the price of AKZA shares?
As of January 21, 2026, the stock is trading at EUR 58.16 with a total of 533,206 shares traded.
Over the past week, the price has changed by -1.39%, over one month by -0.72%, over three months by -3.96% and over the past year by +0.43%.
Over the past week, the price has changed by -1.39%, over one month by -0.72%, over three months by -3.96% and over the past year by +0.43%.
Is AKZA a buy, sell or hold?
Akzo Nobel has no consensus analysts rating.
What are the forecasts/targets for the AKZA price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 69.7 | 19.8% |
| Analysts Target Price | - | - |
| ValueRay Target Price | 59.3 | 1.9% |
AKZA Fundamental Data Overview January 20, 2026
Market Cap USD = 11.76b (10.12b EUR * 1.1624 EUR.USD)
P/E Trailing = 179.2727
P/E Forward = 13.947
P/S = 0.9726
P/B = 2.5743
P/EG = 0.8831
Revenue TTM = 10.53b EUR
EBIT TTM = 792.0m EUR
EBITDA TTM = 1.17b EUR
Long Term Debt = 3.47b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.61b EUR (from shortLongTermDebt, last fiscal year)
Debt = 5.08b EUR (Calculated: Short Term 1.61b + Long Term 3.47b)
Net Debt = 3.77b EUR (from netDebt column, last fiscal year)
Enterprise Value = 13.64b EUR (10.12b + Debt 5.08b - CCE 1.55b)
Interest Coverage Ratio = 4.42 (Ebit TTM 792.0m / Interest Expense TTM 179.0m)
EV/FCF = 28.42x (Enterprise Value 13.64b / FCF TTM 480.0m)
FCF Yield = 3.52% (FCF TTM 480.0m / Enterprise Value 13.64b)
FCF Margin = 4.56% (FCF TTM 480.0m / Revenue TTM 10.53b)
Net Margin = 3.94% (Net Income TTM 415.0m / Revenue TTM 10.53b)
Gross Margin = 39.85% ((Revenue TTM 10.53b - Cost of Revenue TTM 6.33b) / Revenue TTM)
Gross Margin QoQ = 39.53% (prev 40.11%)
Tobins Q-Ratio = 0.96 (Enterprise Value 13.64b / Total Assets 14.17b)
Interest Expense / Debt = 1.34% (Interest Expense 68.0m / Debt 5.08b)
Taxrate = 24.58% (44.0m / 179.0m)
NOPAT = 597.3m (EBIT 792.0m * (1 - 24.58%))
Current Ratio = 1.23 (Total Current Assets 6.33b / Total Current Liabilities 5.16b)
Debt / Equity = 1.22 (Debt 5.08b / totalStockholderEquity, last quarter 4.17b)
Debt / EBITDA = 3.23 (Net Debt 3.77b / EBITDA 1.17b)
Debt / FCF = 7.86 (Net Debt 3.77b / FCF TTM 480.0m)
Total Stockholder Equity = 4.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 415.0m / Total Assets 14.17b)
RoE = 9.25% (Net Income TTM 415.0m / Total Stockholder Equity 4.49b)
RoCE = 9.95% (EBIT 792.0m / Capital Employed (Equity 4.49b + L.T.Debt 3.47b))
RoIC = 8.16% (NOPAT 597.3m / Invested Capital 7.32b)
WACC = 4.83% (E(10.12b)/V(15.20b) * Re(6.75%) + D(5.08b)/V(15.20b) * Rd(1.34%) * (1-Tc(0.25)))
Discount Rate = 6.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.26%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈557.6m ; Y1≈366.0m ; Y5≈167.0m
Fair Price DCF = 9.05 (EV 5.32b - Net Debt 3.77b = Equity 1.55b / Shares 171.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -22.95 | EPS CAGR: -56.09% | SUE: -4.0 | # QB: 0
Revenue Correlation: 26.11 | Revenue CAGR: 2.32% | SUE: -0.97 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=-0.007 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=4.03 | Chg30d=-0.086 | Revisions Net=-4 | Growth EPS=+42.1% | Growth Revenue=-1.1%
P/E Trailing = 179.2727
P/E Forward = 13.947
P/S = 0.9726
P/B = 2.5743
P/EG = 0.8831
Revenue TTM = 10.53b EUR
EBIT TTM = 792.0m EUR
EBITDA TTM = 1.17b EUR
Long Term Debt = 3.47b EUR (from longTermDebt, last fiscal year)
Short Term Debt = 1.61b EUR (from shortLongTermDebt, last fiscal year)
Debt = 5.08b EUR (Calculated: Short Term 1.61b + Long Term 3.47b)
Net Debt = 3.77b EUR (from netDebt column, last fiscal year)
Enterprise Value = 13.64b EUR (10.12b + Debt 5.08b - CCE 1.55b)
Interest Coverage Ratio = 4.42 (Ebit TTM 792.0m / Interest Expense TTM 179.0m)
EV/FCF = 28.42x (Enterprise Value 13.64b / FCF TTM 480.0m)
FCF Yield = 3.52% (FCF TTM 480.0m / Enterprise Value 13.64b)
FCF Margin = 4.56% (FCF TTM 480.0m / Revenue TTM 10.53b)
Net Margin = 3.94% (Net Income TTM 415.0m / Revenue TTM 10.53b)
Gross Margin = 39.85% ((Revenue TTM 10.53b - Cost of Revenue TTM 6.33b) / Revenue TTM)
Gross Margin QoQ = 39.53% (prev 40.11%)
Tobins Q-Ratio = 0.96 (Enterprise Value 13.64b / Total Assets 14.17b)
Interest Expense / Debt = 1.34% (Interest Expense 68.0m / Debt 5.08b)
Taxrate = 24.58% (44.0m / 179.0m)
NOPAT = 597.3m (EBIT 792.0m * (1 - 24.58%))
Current Ratio = 1.23 (Total Current Assets 6.33b / Total Current Liabilities 5.16b)
Debt / Equity = 1.22 (Debt 5.08b / totalStockholderEquity, last quarter 4.17b)
Debt / EBITDA = 3.23 (Net Debt 3.77b / EBITDA 1.17b)
Debt / FCF = 7.86 (Net Debt 3.77b / FCF TTM 480.0m)
Total Stockholder Equity = 4.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.90% (Net Income 415.0m / Total Assets 14.17b)
RoE = 9.25% (Net Income TTM 415.0m / Total Stockholder Equity 4.49b)
RoCE = 9.95% (EBIT 792.0m / Capital Employed (Equity 4.49b + L.T.Debt 3.47b))
RoIC = 8.16% (NOPAT 597.3m / Invested Capital 7.32b)
WACC = 4.83% (E(10.12b)/V(15.20b) * Re(6.75%) + D(5.08b)/V(15.20b) * Rd(1.34%) * (1-Tc(0.25)))
Discount Rate = 6.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -0.26%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈557.6m ; Y1≈366.0m ; Y5≈167.0m
Fair Price DCF = 9.05 (EV 5.32b - Net Debt 3.77b = Equity 1.55b / Shares 171.1m; r=5.90% [WACC]; 5y FCF grow -40.0% → 2.90% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -22.95 | EPS CAGR: -56.09% | SUE: -4.0 | # QB: 0
Revenue Correlation: 26.11 | Revenue CAGR: 2.32% | SUE: -0.97 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=-0.007 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=4.03 | Chg30d=-0.086 | Revisions Net=-4 | Growth EPS=+42.1% | Growth Revenue=-1.1%